Gartner (IT) Competitors $229.63 -14.08 (-5.78%) Closing price 08/7/2025 03:59 PM EasternExtended Trading$230.37 +0.74 (+0.32%) As of 08/7/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock IT vs. CCRN, DOCU, FORR, GOOG, ICFI, ACN, APTV, TRU, TT, and CTSHShould you be buying Gartner stock or one of its competitors? The main competitors of Gartner include Cross Country Healthcare (CCRN), Docusign (DOCU), Forrester Research (FORR), Alphabet (GOOG), ICF International (ICFI), Accenture (ACN), Aptiv (APTV), TransUnion (TRU), Trane Technologies (TT), and Cognizant Technology Solutions (CTSH). Gartner vs. Its Competitors Cross Country Healthcare Docusign Forrester Research Alphabet ICF International Accenture Aptiv TransUnion Trane Technologies Cognizant Technology Solutions Gartner (NYSE:IT) and Cross Country Healthcare (NASDAQ:CCRN) are both business services companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, profitability, risk, valuation, institutional ownership, dividends, media sentiment and earnings. Which has more volatility and risk, IT or CCRN? Gartner has a beta of 1.19, suggesting that its stock price is 19% more volatile than the S&P 500. Comparatively, Cross Country Healthcare has a beta of 0.35, suggesting that its stock price is 65% less volatile than the S&P 500. Which has better valuation and earnings, IT or CCRN? Gartner has higher revenue and earnings than Cross Country Healthcare. Cross Country Healthcare is trading at a lower price-to-earnings ratio than Gartner, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGartner$6.30B2.81$1.25B$16.0714.29Cross Country Healthcare$1.34B0.31-$14.56M-$0.53-23.64 Is IT or CCRN more profitable? Gartner has a net margin of 19.71% compared to Cross Country Healthcare's net margin of -0.70%. Gartner's return on equity of 82.63% beat Cross Country Healthcare's return on equity.Company Net Margins Return on Equity Return on Assets Gartner19.71% 82.63% 13.58% Cross Country Healthcare -0.70%1.71%1.22% Do institutionals & insiders hold more shares of IT or CCRN? 91.5% of Gartner shares are owned by institutional investors. Comparatively, 96.0% of Cross Country Healthcare shares are owned by institutional investors. 2.3% of Gartner shares are owned by insiders. Comparatively, 4.9% of Cross Country Healthcare shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Does the media prefer IT or CCRN? In the previous week, Gartner had 64 more articles in the media than Cross Country Healthcare. MarketBeat recorded 73 mentions for Gartner and 9 mentions for Cross Country Healthcare. Gartner's average media sentiment score of 0.28 beat Cross Country Healthcare's score of 0.23 indicating that Gartner is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Gartner 19 Very Positive mention(s) 4 Positive mention(s) 22 Neutral mention(s) 16 Negative mention(s) 3 Very Negative mention(s) Neutral Cross Country Healthcare 2 Very Positive mention(s) 0 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do analysts prefer IT or CCRN? Gartner presently has a consensus price target of $369.25, suggesting a potential upside of 60.80%. Cross Country Healthcare has a consensus price target of $17.93, suggesting a potential upside of 43.10%. Given Gartner's stronger consensus rating and higher probable upside, analysts plainly believe Gartner is more favorable than Cross Country Healthcare.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Gartner 1 Sell rating(s) 4 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.25Cross Country Healthcare 0 Sell rating(s) 6 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 SummaryGartner beats Cross Country Healthcare on 14 of the 16 factors compared between the two stocks. Get Gartner News Delivered to You Automatically Sign up to receive the latest news and ratings for IT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding IT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IT vs. The Competition Export to ExcelMetricGartnerConsulting IndustryBusiness SectorNYSE ExchangeMarket Cap$18.76B$6.72B$20.73B$20.70BDividend YieldN/A1.81%2.83%3.67%P/E Ratio14.1323.1627.4528.64Price / Sales2.812.5145.1057.35Price / Cash14.4016.3728.1823.59Price / Book11.535.245.654.32Net Income$1.25B$272.15M$197.12M$995.66M7 Day Performance-30.12%-0.59%1.71%1.91%1 Month Performance-42.42%-8.18%-2.69%-0.54%1 Year Performance-52.06%-8.49%33.77%14.76% Gartner Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ITGartner4.9197 of 5 stars$229.63-5.8%$369.25+60.8%-50.9%$18.76B$6.30B14.1321,044Trending NewsEarnings ReportAnalyst ForecastAnalyst RevisionHigh Trading VolumeCCRNCross Country Healthcare3.6718 of 5 stars$13.81+1.5%$17.93+29.8%-20.4%$452.69M$1.34B-26.068,205Earnings ReportDOCUDocusign4.8849 of 5 stars$80.39+0.7%$89.77+11.7%+38.1%$16.24B$2.98B15.206,838FORRForrester Research3.8285 of 5 stars$10.80+4.0%N/A-43.6%$205.85M$432.47M-2.361,571Analyst RevisionGOOGAlphabet4.7715 of 5 stars$193.42-0.3%$215.19+11.3%+22.7%$2.35T$371.40B20.60190,200Trending NewsInsider TradeICFIICF International4.437 of 5 stars$84.39-2.0%$127.20+50.7%-40.6%$1.55B$2.02B14.489,300Earnings ReportDividend AnnouncementAnalyst RevisionACNAccenture4.986 of 5 stars$277.01-2.2%$365.43+31.9%-24.0%$173.50B$64.90B22.05774,000Positive NewsOptions VolumeAPTVAptiv4.6489 of 5 stars$69.81-1.6%$81.63+16.9%-3.2%$15.20B$19.71B11.56141,000Positive NewsAnalyst ForecastTRUTransUnion4.5444 of 5 stars$98.18-1.0%$112.46+14.5%+8.9%$19.15B$4.36B49.0913,400TTTrane Technologies3.929 of 5 stars$472.45+0.1%$441.40-6.6%+32.3%$105.37B$19.84B39.3145,000Analyst ForecastCTSHCognizant Technology Solutions4.9336 of 5 stars$75.42-1.6%$85.88+13.9%-5.5%$37.18B$19.74B15.88336,800Positive News Related Companies and Tools Related Companies CCRN Alternatives DOCU Alternatives FORR Alternatives GOOG Alternatives ICFI Alternatives ACN Alternatives APTV Alternatives TRU Alternatives TT Alternatives CTSH Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:IT) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredSell this, buy thatWhat you don’t own matters just as much as what you do. That’s the thinking behind Eric Fry’s long-time strate...InvestorPlace | SponsoredAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | SponsoredAltucher: Trump’s Great Gain is startingNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredCritical AI announcement set to ignite AI 2.0 A new 100% tariff on imported chips just rattled the tech sector—sending some stocks soaring and others tumbli...Timothy Sykes | SponsoredTrump’s new nightmareAccording to Porter Stansberry and Jeff Brown, a government-led financial mobilization is already reshaping Am...Porter & Company | SponsoredThe Day Silicon DiesThe Day China Left America's Supercomputers in the Dust In 200 seconds, China's quantum computer accomplish...The Oxford Club | SponsoredThis accelerated income plan is solving American's #1 retirement fearThe #1 fear in retirement today? Running out of money. That’s why income expert Tim Plaehn created a simple...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Gartner, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Gartner With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.